
2028年までの北米医療用光生体刺激システム市場予測 - 製品(赤外線、赤色光など)および用途(疼痛管理、創傷ケア、化粧品用途など)ごとの新型コロナウイルス感染症の影響と地域分析
No. of Pages: 101 | Report Code: TIPRE00025568 | Category: Life Sciences
No. of Pages: 101 | Report Code: TIPRE00025568 | Category: Life Sciences
慢性的な痛みに苦しむ患者の数が増加しています。 2019 年の国民健康面接調査 (NHIS) によると、米国成人における慢性疼痛の有病率は 20.4% で、うち衝撃性の高い慢性疼痛が 7.4% を占めています。慢性疼痛の発生率は、65歳以上(30.8%)、非ヒスパニック系白人成人(23.6%)、女性(21.7%)で最も高かった。衝撃の強い慢性疼痛は、65歳以上の人々(11.8%)と女性(8.5%)で最も高かった。医療用光生体刺激システムは、痛み、炎症、浮腫を軽減するために使用されます。傷、深部組織、神経の治癒を促進します。そして組織の損傷を防ぎます。したがって、慢性疼痛やその他の慢性疾患に苦しむ患者の急増が、北米の医療用光生体刺激システム市場を牽引しています。
新しい機能やテクノロジーがあれば、ベンダーは新しい顧客を引き付け、新興市場での拠点を拡大できます。この要因により、予測期間中に医療用光生体刺激システム市場が有望な CAGR で推進される可能性があります。
北米の医療用光生体刺激システム市場は製品とアプリケーションに分割されます。製品に基づいて、市場は赤外線、赤色光などに分類されます。用途に基づいて、市場は疼痛管理、創傷ケア、化粧品用途などに分類されます。地理的に、北米の医療用光生体刺激システム市場は、米国、カナダ、メキシコに分割されています。
BioLight Technologies LLC.、Omega Laser Systems Ltd、Vielight Inc.、Theradome Inc.、Lexington Intl., LLC、THOR Photomedicine Ltd、iRestore Hair Growth System、Meditech International Inc. (BIOFLEX Laser Therapy)、および Apira Science, Inc. (iGrow Laser) が主要企業です。北米の医療用光生体刺激システム市場の企業。
Strategic insights for North America Medical Photobiostimulation System involve closely monitoring industry trends, consumer behaviours, and competitor actions to identify opportunities for growth. By leveraging data analytics, businesses can anticipate market shifts and make informed decisions that align with evolving customer needs. Understanding these dynamics helps companies adjust their strategies proactively, enhance customer engagement, and strengthen their competitive edge. Building strong relationships with stakeholders and staying agile in response to changes ensures long-term success in any market.
Report Attribute | Details |
---|---|
Market size in 2021 | US$ 89.4 Million |
Market Size by 2028 | US$ 139.6 Million |
Global CAGR (2021 - 2028) | 6.6% |
Historical Data | 2019-2020 |
Forecast period | 2022-2028 |
Segments Covered |
By 製品
|
Regions and Countries Covered | 北米
|
Market leaders and key company profiles |
The regional scope of North America Medical Photobiostimulation System refers to the geographical area in which a business operates and competes. Understanding regional nuances, such as local consumer preferences, economic conditions, and regulatory environments, is crucial for tailoring strategies to specific markets. Businesses can expand their reach by identifying underserved regions or adapting their offerings to meet regional demands. A clear regional focus allows for more effective resource allocation, targeted marketing, and better positioning against local competitors, ultimately driving growth in those specific areas.
The North America Medical Photobiostimulation System Market is valued at US$ 89.4 Million in 2021, it is projected to reach US$ 139.6 Million by 2028.
As per our report North America Medical Photobiostimulation System Market, the market size is valued at US$ 89.4 Million in 2021, projecting it to reach US$ 139.6 Million by 2028. This translates to a CAGR of approximately 6.6% during the forecast period.
The North America Medical Photobiostimulation System Market report typically cover these key segments-
The historic period, base year, and forecast period can vary slightly depending on the specific market research report. However, for the North America Medical Photobiostimulation System Market report:
The North America Medical Photobiostimulation System Market is populated by several key players, each contributing to its growth and innovation. Some of the major players include:
The North America Medical Photobiostimulation System Market report is valuable for diverse stakeholders, including:
Essentially, anyone involved in or considering involvement in the North America Medical Photobiostimulation System Market value chain can benefit from the information contained in a comprehensive market report.